Chun-Wang Lui

The fairness paradox in public regulatory summaries of FDA-authorized artificial intelligence-enabled medical devices

This Perspective proposes that public summaries may be technically and procedurally detailed while providing only limited entry points for assessing fairness, clinical equity, and accountability in public disclosures, and considers three ways in which these disclosure genres may limit fairness scrutiny.